Evaluating the Neurobiological Basis of Traumatic Dissociation in Women with Histories of Abuse and Neglect
Launched by MCLEAN HOSPITAL · Apr 29, 2016
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Dissociative symptoms commonly are associated with exposure to traumatic stress. Preliminary evidence from functional magnetic resonance imaging-based analysis (fMRI) of neural activation during dissociative symptom provocation in patients with PTSD or DID has implicated certain key structures involved in the generation of dissociative symptoms. Given the presumed region-to-region neural interplay implicit within this model, the investigators believe the use of intrinsic functional connectivity MRI (fcMRI) represents a valuable next line of investigation into the neurobiology of traumatic d...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Female
- • Clinical diagnosis of PTSD or DID and history of childhood abuse, or healthy controls
- • Age between 18 and 89
- • Legal and mental competency of the patient
- Exclusion Criteria:
- • Male
- • Under 18 or over 89
- • Legal or mental incompetence
- • Delirium secondary to medical illness
- • PTSD or DID due to general medical or neurological illness
- • History of neurological conditions that may cause significant psychiatric symptomatology (e.g., dementia)
- • Any contraindication to MR scans, including claustrophobia, pregnancy, metal implants, etc.
- • Current alcohol or substance dependence or abuse (within the last month)
- • A history of schizophrenia or other psychotic disorder
- • History of head injury or loss of consciousness for longer than 5 min (including concussion)
About Mclean Hospital
McLean Hospital, a leading psychiatric affiliate of Harvard Medical School, is dedicated to advancing mental health care through innovative research and clinical trials. Renowned for its commitment to scientific excellence, McLean harnesses a multidisciplinary approach to address a wide range of psychiatric disorders, including depression, anxiety, and schizophrenia. With state-of-the-art facilities and a team of expert clinicians and researchers, the hospital aims to develop effective treatment strategies and improve patient outcomes. Its robust clinical trial program fosters collaboration and contributes to the broader understanding of mental health, ultimately enhancing therapeutic options for individuals in need.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Belmont, Massachusetts, United States
Patients applied
Trial Officials
Milissa L Kaufman, M.D./Ph.D
Principal Investigator
Mclean Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials